Fmr LLC Adaptive Biotechnologies Corp Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Fmr LLC holds 115,601 shares of ADPT stock, worth $532,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,601

Previous 106,177 8.88%

Holding current value

$532,920

Previous $340,000 22.94%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.34 - $3.96 $22,052 - $37,319	9,424 Added 8.88%	115,601 $418,000
Q1 2024 May 13, 2024	SELL	$2.88 - $4.8 $46 - $76	-16 Reduced 0.02%	106,177 $340,000
Q4 2023 Feb 13, 2024	SELL	$3.46 - $5.33 $41,890 - $64,530	-12,107 Reduced 10.23%	106,193 $520,000
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $26,774 - $44,571	5,281 Added 4.67%	118,300 $644,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $135,158 - $191,711	21,835 Added 23.95%	113,019 $758,000
Q1 2023 May 11, 2023	BUY	$7.8 - $10.11 $468 - $606	60 Added 0.07%	91,184 $805,000
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $25,115 - $37,472	4,012 Added 4.61%	91,124 $696,000
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $485,036 - $945,448	74,621 Added 597.4%	87,112 $620,000
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $40,326 - $92,813	6,301 Added 101.79%	12,491 $101,000
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $11.5 Million - $32.9 Million	-1,138,262 Reduced 99.46%	6,190 $86,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $28.8 Million - $42.1 Million	1,143,169 Added 89101.25%	1,144,452 $32.1 Million
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $786,043 - $1.04 Million	-26,184 Reduced 95.33%	1,283 $43,000
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $884,986 - $1.22 Million	27,467 New	27,467 $1.12 Million

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $659M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account